{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:08:46Z","timestamp":1754093326993,"version":"3.41.2"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1023\/a:1007597713530","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:04:10Z","timestamp":1040533450000},"page":"1426-1431","source":"Crossref","is-referenced-by-count":13,"title":["Absorption and Disposition of a Selective Aldosterone Receptor Antagonist, Eplerenone, in the Dog"],"prefix":"10.1007","volume":"17","author":[{"given":"Chyung S","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JuDee S","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"229756_CR1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","volume":"240","author":"M. de Gasparo","year":"1987","unstructured":"M. de Gasparo, U. Joss, H. P. Ramjoue, S. E. Whitebread, H. Haenni, L. Schenkel, C. Kraehenbuehl, M. Biollaz, J. Grob, J. Schmidlin, J. P. Wieland, and H. U. Wehrli. Three new epoxy-spironolactone derivatives: Characterization in vivo and in vitro. J. Pharmacol. Exp. Ther.\n240:650-656 (1987).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"229756_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","volume":"2","author":"A. D. Struthers","year":"1996","unstructured":"A. D. Struthers. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. J. Card. Fail.\n2:47-54 (1996).","journal-title":"J. Card. Fail."},{"key":"229756_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J. Staessen","year":"1981","unstructured":"J. Staessen, P. Lijnen, R. Fagard, L. J. Verschueren, and A. Amery. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J. Endocrinol.\n91:457-465 (1981).","journal-title":"J. Endocrinol."},{"key":"229756_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","volume":"35","author":"R. J. MacFadyen","year":"1997","unstructured":"R. J. MacFadyen, C. S. Barr, and A. D. Struthers. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc. Res.\n35:30-34 (1997).","journal-title":"Cardiovasc. Res."},{"key":"229756_CR5","unstructured":"T. Dwain and A. Karim. Unpublished data (Searle Document No. NE3-99-21-900)."},{"key":"229756_CR6","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1011981317451","volume":"15","author":"W. L. Chiu","year":"1998","unstructured":"W. L. Chiu and A. Barve. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm. Res.\n15:1792-1795 (1998).","journal-title":"Pharm. Res."},{"key":"229756_CR7","first-page":"1707","volume-title":"Goodman and Gilman's The pharmacological basis of therapeutics","author":"L. Z. Benet","year":"1996","unstructured":"L. Z. Benet, S. Oie, and J. B. Schwartz. Design and optimization of dosage regiments: Pharmacokinetic data. In J. G. Hardman and L. E. Limbird (eds.), Goodman and Gilman's The pharmacological basis of therapeutics, McGraw-Hill, New York, 1996 pp. 1707-1792."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007597713530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007597713530\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007597713530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:44:12Z","timestamp":1754034252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007597713530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["229756"],"URL":"https:\/\/doi.org\/10.1023\/a:1007597713530","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}